The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial

Scot Garg, Patrick W Serruys, Sigmund Silber, Joanna Wykrzykowska, Robert Jan van Geuns, Gert Richardt, Pawel E Buszman, Henning Kelbæk, Adrianus Johannes van Boven, Sjoerd H Hofma, Axel Linke, Volker Klauss, William Wijns, Carlos Macaya, Philippe Garot, Carlo DiMario, Ganesh Manoharan, Ran Kornowski, Thomas Ischinger, Antonio BartorelliEric Van Remortel, Jacintha Ronden, Stephan Windecker

    95 Citationer (Scopus)

    Abstract

    This study assessed the ability of the SYNTAX score (SXscore) to stratify risk in patients treated with percutaneous coronary intervention (PCI) using zotarolimus-eluting or everolimus-eluting stents.
    OriginalsprogEngelsk
    TidsskriftJACC. Cardiovascular interventions
    Vol/bind4
    Udgave nummer4
    Sider (fra-til)432-41
    Antal sider10
    DOI
    StatusUdgivet - 2011

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial'. Sammen danner de et unikt fingeraftryk.

    Citationsformater